Dr. Zhuo Yang 杨卓
Chief Physician, Associate Professor
Gynecology Ward 5, Liaoning Cancer Hospital & Institute, Shenyang
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Minimally invasive surgery for benign and malignant gynecologic conditions, including single-port laparoscopy and Da Vinci robotic procedures. Focuses on individualized treatment, fertility preservation, and clinical trials for refractory or recurrent gynecologic cancers.
Dr. Yang is Chief Physician, Associate Professor, and Deputy Director of the Gynecology Department at Liaoning Cancer Hospital & Institute. Holding a PhD and having completed postdoctoral research at the University of California, Los Angeles, Dr. Yang studies cervical cancer preoperative assessment, ovarian cancer chemotherapy resistance, and targeted therapies.
Professional roles
- Chair, Gynecologic Oncology Branch, Liaoning Medical Association
- Member, Scientific Network Management Committee, US Helics Group
- Member, Tumor Endocrinology Professional Committee, China Anti-Cancer Association
- Chair, Youth Committee, Gynecologic Oncology Branch, Liaoning Medical Association
Name order: in Chinese the family name comes first (Yang Zhuo). Papers usually list the name as Zhuo Yang or Yang Z.
Selected publications
28 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- Genes Dis, 2025 (senior author): Restriction of YWHAB-mediated YAP cytoplasmic retention is a novel mechanism underlying stemness maintenance and chemoresistance in ovarian cancer peritoneal metastasis. PubMed 40612667
- J Assist Reprod Genet, 2025 (senior author): Current status of fertility preservation procedures in gynecologic oncology: from a Chinese perspective. PubMed 39812764
- Small, 2024 (senior author): Tumor-Specific Nano-Herb Delivery System with High L-Arginine Loading for Synergistic Chemo and Gas Therapy against Cervical Cancer. PubMed 39101346
- Oxid Med Cell Longev, 2022 (senior author): Identifying the Role of Oxidative Stress-Related Genes as Prognostic Biomarkers and Predicting the Response of Immunotherapy and Chemotherapy in Ovarian Cancer. PubMed 36561981
- Front Nutr, 2022 (senior author): Corrigendum: Association Between Pre-diagnostic Dietary Supplements Intake and Ovarian Cancer Survival: Findings From a Prospective Cohort Study in Chinese Women. PubMed 35223966
- Front Nutr, 2021 (senior author): Association Between Pre-diagnostic Dietary Supplements Intake and Ovarian Cancer Survival: Findings From a Prospective Cohort Study in Chinese Women. PubMed 34970575
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion